Quantcast
Last updated on April 21, 2014 at 7:50 EDT

Latest STAAR Surgical Company Stories

2014-04-17 08:27:54

MONROVIA, Calif., April 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close. STAAR will host a conference call and video webcast on Monday, April 28 at 4:15 p.m. Eastern / 1:15 p.m. Pacific to discuss these results and...

2014-03-17 08:28:35

First of Kind Product in the U.S. MONROVIA, Calif., March 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and...

2014-03-03 08:33:17

Over 50,000 ICLs Successfully Implanted with CentraFLOW Driven by the KS-AquaPORT Technology(TM) MONROVIA, Calif., March 3, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry of Health, Labor and Welfare. With this...

2014-02-24 08:27:27

MONROVIA, Calif., Feb. 24, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET. Barry Caldwell, President and CEO, and Steve Brown, CFO will present a general overview of the business, the Company's recent financial...

2014-02-14 08:25:48

MONROVIA, Calif., Feb. 14, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close. STAAR will host a conference call and webcast on Wednesday, February 26 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss these results and recent corporate...

2014-02-13 08:30:12

MONROVIA, Calif., Feb. 13, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported the U.S. Food & Drug Administration's Ophthalmic Devices Panel of the Medical Devices Advisory Committee meeting scheduled for Friday, February 14, 2014 has been postponed due to weather. The Agency has assured the Company that it intends to reschedule the meeting as soon as practically...

2014-01-30 08:30:06

Appointment Expands Board to Seven Members MONROVIA, Calif., Jan. 30, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a...

2013-11-21 12:28:36

MONROVIA, Calif., Nov. 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry Caldwell, President and CEO, and Steve Brown, CFO, will participate in a fireside chat at the 25th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel on Tuesday, December 3 at 3:00 p.m. ET. STAAR will offer a live audio webcast of its presentation on the...

2013-11-14 12:27:20

MONROVIA, Calif., Nov. 14, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it is hosting an investor breakfast and webcast on Saturday, November 16 during the American Academy of Ophthalmology (AAO) Annual Meeting in New Orleans, LA. Dr. Erik Mertens, Medical Director and founder of the Medipolis Eye Centre in Antwerp, Belgium, will provide an update on...

2013-11-05 08:33:28

~Stephens Fall Investment Conference on November 13 MONROVIA, Calif., Nov. 5, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in two upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties. Barry Caldwell, President and CEO, and Steve Brown, CFO, will...